From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan
Per protocol (PP) evaluation
Group I
Group II
Group III
Overall
Mean (95% CI)
69 (49-89)
33 (29-37)
45 (34-56)
49 (41-57)
Median (95% CI)
63 (47-79)
32 (27-37)
35 (21-49)
37 (31-43)